Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infertility in Males01:23

Infertility in Males

670
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
670
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

3.5K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
3.5K
Menopause01:28

Menopause

5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Testes: Gross Anatomy01:19

Testes: Gross Anatomy

9.8K
The testes, also known as testicles, are the male gonads. They are housed within the scrotum, a sac-like structure located beneath the penis. The scrotum's primary role is to regulate the temperature of the testes, which is crucial for sperm production.
Each testis is surrounded by the tunica albuginea, a dense connective tissue layer that provides structural support and protection. This layer is covered by an outer serous membrane called the tunica vaginalis, which helps reduce friction...
9.8K
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

3.9K
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low Serum Testosterone Concentrations Predict Incident Frailty in Men with HIV.

The Journal of clinical endocrinology and metabolism·2026
Same author

Testosterone and Bone Health in Men.

Current osteoporosis reports·2026
Same author

Impact of Pre-treatment Testosterone Levels on Severity of Adverse Effects in Men on Androgen Deprivation Therapy for Prostate Cancer.

Andrology·2026
Same author

Opioid-induced androgen deficiency in men: Prevalence, pathophysiology, and efficacy of testosterone therapy.

Andrology·2025
Same author

Insulin resistance during androgen deprivation therapy in men with prostate cancer.

Cancer·2024
Same author

Selective Androgen Receptor Modulators-Transformative Drugs or Heralds of the Next Drug Epidemic?

JAMA·2024
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
Same journal

Indonesia's health reform: from pandemic mandate to the six pillars of transformation.

Lancet (London, England)·2026
Same journal

LGBTQ+ Russians increasingly avoiding doctors.

Lancet (London, England)·2026
See all related articles

Related Experiment Video

Updated: May 7, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.3K

Male hypogonadism.

Shehzad Basaria1

  • 1Section on Men's Health, Aging and Metabolism, Division of Endocrinology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Lancet (London, England)
|October 15, 2013
PubMed
Summary
This summary is machine-generated.

Male hypogonadism, a condition of low testosterone or sperm production, requires diagnosis via symptoms and confirmed low testosterone levels. Treatment involves testosterone replacement therapy, with careful monitoring for benefits and adverse effects.

More Related Videos

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.7K
Gonadectomy and Blood Sampling Procedures in the Small Size Teleost Model Japanese Medaka Oryzias latipes
05:31

Gonadectomy and Blood Sampling Procedures in the Small Size Teleost Model Japanese Medaka Oryzias latipes

Published on: December 11, 2020

4.1K

Related Experiment Videos

Last Updated: May 7, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.3K
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.7K
Gonadectomy and Blood Sampling Procedures in the Small Size Teleost Model Japanese Medaka Oryzias latipes
05:31

Gonadectomy and Blood Sampling Procedures in the Small Size Teleost Model Japanese Medaka Oryzias latipes

Published on: December 11, 2020

4.1K

Area of Science:

  • Endocrinology
  • Urology
  • Men's Health

Background:

  • Male hypogonadism is a syndrome characterized by insufficient testosterone production or sperm count.
  • It can stem from primary testicular issues or secondary hypothalamic-pituitary dysfunction.
  • Symptoms and presentation vary based on onset, cause, genetics, and prior androgen therapy.

Purpose of the Study:

  • To define male hypogonadism, its causes, and diagnostic criteria.
  • To outline available testosterone replacement therapies and their selection criteria.
  • To detail contraindications and monitoring requirements for testosterone therapy.

Main Methods:

  • Diagnosis relies on clinical signs of androgen deficiency and repeated low morning serum testosterone levels.
  • Treatment selection considers patient preference, cost, availability, and formulation.
  • Monitoring involves assessing therapeutic benefits and potential adverse effects.

Main Results:

  • Male hypogonadism presents with diverse clinical features depending on the underlying cause and timing of androgen deficiency.
  • Accurate diagnosis requires consistent low testosterone levels alongside characteristic symptoms.
  • Testosterone replacement therapy offers treatment options but has specific contraindications and requires careful management.

Conclusions:

  • Male hypogonadism is a treatable condition diagnosed through clinical evaluation and hormonal assays.
  • Therapeutic decisions for testosterone replacement should be individualized.
  • Close monitoring is essential to ensure treatment efficacy and patient safety.